1,860
Participants
Start Date
August 15, 2019
Primary Completion Date
July 23, 2035
Study Completion Date
July 23, 2035
Standard of care
Treatment as per standard practice
Investigational Site Number : 0320006, Buenos Aires
Investigational Site Number : 0320001, Buenos Aires
Investigational Site Number : 0320002, Buenos Aires
Investigational Site Number : 0320008, Buenos Aires
Investigational Site Number : 0320004, Rosario
Investigational Site Number : 0360011, Sydney
Investigational Site Number : 0360008, Kogarah
Investigational Site Number : 2080002, København NV
Investigational Site Number : 0360009, Sydney
Investigational Site Number : 0360003, Parkville
Investigational Site Number : 0360007, Richmond
Investigational Site Number : 0360010, Melbourne
Investigational Site Number : 0320007, San Miguel de Tucumán
Investigational Site Number : 5780003, Stavanger
Investigational Site Number : 0320010, Córdoba
Investigational Site Number : 5780001, Bergen
Investigational Site Number : 0320009, Bahía Blanca
Park Plaza Dermatology- Site Number : 8400080, New York
Philip Fried, M.D., PLLC- Site Number : 8400029, The Bronx
Tiga Pediatrics, PC- Site Number : 8400037, The Bronx
Investigational Site Number : 2500006, Marseille
Investigational Site Number : 2500005, Martigues
Investigational Site Number : 4100008, Ansan-si
Investigational Site Number : 4100002, Suwon
Investigational Site Number : 3800001, Milan
Dermatology Associates PC- Site Number : 8400049, Rockville
Investigational Site Number : 4100007, Incheon
Investigational Site Number : 3800014, Brescia
Investigational Site Number : 3800015, Pavia
UNC Hospitals- Site Number : 8400016, Chapel Hill
2G Clinical Research Services- Site Number : 8400031, Durham
Investigational Site Number : 7240003, Madrid
Investigational Site Number : 7240010, Madrid
Clinical Research Of Gastonia- Site Number : 8400041, Gastonia
Investigational Site Number : 7240012, Pozuelo de Alarcón
MUSC- Site Number : 8400013, Charleston
ADAC Research- Site Number : 8400048, Greenville
Investigational Site Number : 2500011, Toulouse
Centricity Research Talbotton - DBA IACT Health Research at Talbotton Site Number : 8400056, Columbus
Pediatric & Adult Research Center- Site Number : 8400040, Orlando
Amedica Research Institute, Inc.- Site Number : 8400067, Hialeah
Eastern Research, Inc.- Site Number : 8400032, Hialeah
Elias Dermatology LLC- Site Number : 8400086, Pembroke Pines
Elias Dermatology LLC- Site Number : 8400087, Pembroke Pines
Premier Dermatology Partners- Site Number : 8400075, Miami
Pediatric Center of Excellence (PCE) - Miami Pediatric Endocrinology, LLC- Site Number : 8400072, Coral Gables
Nicklaus Children's Hospital - Miami - Southwest 62nd Avenue- Site Number : 8400074, Miami
Vista Health Research, LLC- Site Number : 8400034, Miami
Daxia Trials- Site Number : 8400082, Boca Raton
Green Dermatology and Cosmetic Center. Site Number : 8400078, Deerfield Beach
Frieder Dermatology- Site Number : 8400085, Boca Raton
Investigational Site Number : 7240009, Mieres
Investigational Site Number : 2500001, Bordeaux
Investigational Site Number : 3800007, Trieste
Investigational Site Number : 3800011, Padua
Investigational Site Number : 3800006, Padua
C Squared Research Center- Site Number : 8400068, Birmingham
Cahaba Dermatology & Skin Health Center- Site Number : 8400046, Birmingham
C2 Research Center, LLC- Site Number : 8400071, Montgomery
Investigational Site Number : 3800003, Bologna
Michael W. Simon, M.D., PSC- Site Number : 8400073, Lexington
Investigational Site Number : 3800013, Reggio Emilia
Dermatology Associates of Mid-Ohio- Site Number : 8400052, Marion
Investigational Site Number : 2500002, Nantes
Cincinnati Children's Hospital Medical Center- Site Number : 8400017, Cincinnati
The Indiana Clinical Trial Center - Plainfield - Edwards Drive- Site Number : 8400007, Plainfield
The Indiana Clinical Trials Center, PC Site Number : 8400007, Plainfield
Michigan Dermatology Institute Site Number : 8400059, Waterford
Medical College Of Wisconsin- Site Number : 8400008, Milwaukee
Investigational Site Number : 4840005, Tlalnepantla
Investigational Site Number : 3000005, Thessaloniki
Investigational Site Number : 3000003, Thessaloniki
Investigational Site Number : 2500010, Lille
NorthShore University HealthSystem - Skokie- Site Number : 8400064, Skokie
Northwestern University Feinberg School of Medicine- Site Number : 8400001, Chicago
Investigational Site Number : 4840010, Cuernavaca
Investigational Site Number : 4840003, Monterrey
Investigational Site Number : 4840009, Monterrey
Investigational Site Number : 4840008, Monterrey
Investigational Site Number : 3800012, Bari
Investigational Site Number : 4840004, Puebla City
Investigational Site Number : 2500003, Paris
Heights Dermatology & Aesthetic Center- Site Number : 8400065, Houston
The Dermatology Institute of South Texas- Site Number : 8400076, McAllen
Amarillo Center for Clinical Research- Site Number : 8400055, Amarillo
Investigational Site Number : 3800008, Naples
Investigational Site Number : 3800005, Napoli
Phoenix Children's Hospital, Inc.- Site Number : 8400015, Phoenix
Axis Clinical Trials- Site Number : 8400025, Los Angeles
Orange County Research Institute- Site Number : 8400028, Anaheim
Carey Chronis, MD, FAAP- Site Number : 8400033, Ventura
Madera Family Medical Group- Site Number : 8400054, Madera
Investigational Site Number : 2500008, Argenteuil
Investigational Site Number : 3800010, Catania
Investigational Site Number : 1560004, Beijing
Investigational Site Number : 6430005, Moscow
Investigational Site Number : 1700001, Bogotá
Investigational Site Number : 1700004, Bogotá
Investigational Site Number : 6430002, Moscow
Investigational Site Number : 6430003, Moscow
Investigational Site Number : 6430001, Moscow
Investigational Site Number : 6430004, Moscow
Investigational Site Number : 1560007, Harbin
Investigational Site Number : 1560005, Shanghai
Investigational Site Number : 1560002, Suzhou
Investigational Site Number : 1560008, Xuzhou
Investigational Site Number : 1560001, Chongqing
Investigational Site Number : 1560006, Changsha
Investigational Site Number : 1560012, Guangzhou
Investigational Site Number : 1560011, Shenzhen
Investigational Site Number : 3760004, Haifa
Investigational Site Number : 3760005, Kefar Sava
Investigational Site Number : 3760001, Ramat Gan
Investigational Site Number : 3760002, Rehovot
Investigational Site Number : 3760003, Beersheba
Tokunbo T. Dada, MD PA- Site Number : 8400079, Irvington
Family Pediatrics Iwuozo L Obilo Md- Site Number : 8400077, Newark
Providence Medical Center- Site Number : 8400081, North Plainfield
VAMA Medical Health Center- Site Number : 8400083, Union
Investigational Site Number : 0320003, Ciudad Autonoma de Buenos Aires
Investigational Site Number : 0320005, Ciudad Autonoma Buenos Aires
Investigational Site Number : 0320013, Salta
Investigational Site Number : 0320007, San Miguel de Tucumán
Universidade Federal do Paraná- Site Number : 0760003, Curitiba
Hospital de Clinicas da Universidade Federal do Parana- Site Number : 0760004, Curitiba
Hospital de Clinicas da Universidade Federal do Parana- Site Number : 0760005, Curitiba
Irmandade da Santa Casa de Misericórdia de Porto Alegre- Site Number : 0760002, Porto Alegre
Clinica de Alergia Martti Antila- Site Number : 0760001, Sorocaba
IDERJ - Instituto de Dermatologia e Estética do Brasil- Site Number : 0760009, Rio de Janeiro
Fundacao Faculdade Regional de Medicina de Sao Jose do Rio Preto- Site Number : 0760007, Sao Jose Rio Preto
Hospital Sao Paulo- Site Number : 0760006, São Paulo
Investigational Site Number : 1240004, Calgary
Investigational Site Number : 1240007, Calgary
Investigational Site Number : 1240005, Winnipeg
Investigational Site Number : 1240010, Halifax
Investigational Site Number : 1240001, Markham
Investigational Site Number : 1240008, Toronto
Investigational Site Number : 1240006, Montreal
Investigational Site Number : 1240009, Regina
Investigational Site Number : 1700006, Barranquilla
Investigational Site Number : 3000004, Larissa
Investigational Site Number : 3000002, Thessaloniki
Investigational Site Number : 3800004, Terracina
Investigational Site Number : 3800009, Perugia
Investigational Site Number : 3800018, Roma
Investigational Site Number : 3920009, Sagamihara
Investigational Site Number : 3920016, Yokohama
Investigational Site Number : 3920016, Yokohama
Investigational Site Number : 3920010, Tsu
Investigational Site Number : 3920003, Habikino
Investigational Site Number : 3920011, Fuchū
Investigational Site Number : 3920018, Fukuoka
Investigational Site Number : 3920017, Fukuyama-shi
Investigational Site Number : 3920002, Hiroshima
Investigational Site Number : 3920015, Kumagaya-shi
Investigational Site Number : 3920004, Kyoto
Investigational Site Number : 3920012, Nagasaki
Investigational Site Number : 3920020, Nagoya
Investigational Site Number : 3920008, Obu-shi
Investigational Site Number : 3920005, Osakasayama-shi
Investigational Site Number : 3920014, Sendai
Investigational Site Number : 3920019, Sendai
Investigational Site Number : 3920001, Tokyo
Investigational Site Number : 4840001, México
Investigational Site Number : 4840006, México
Investigational Site Number : 5280001, Amsterdam
Investigational Site Number : 5280005, Groningen
Investigational Site Number : 5280002, Rotterdam
Investigational Site Number : 5280006, The Hague
Investigational Site Number : 5280003, Utrecht
Investigational Site Number : 5780002, Oslo
Investigational Site Number : 6200003, Braga
Investigational Site Number : 6200005, Lisbon
Investigational Site Number : 6200001, Lisbon
Investigational Site Number : 6200006, Porto
Investigational Site Number : 4100001, Seoul
Investigational Site Number : 4100003, Seoul
Investigational Site Number : 4100005, Seoul
Investigational Site Number : 4100004, Seoul
Investigational Site Number : 7240005, Barcelona
Investigational Site Number : 7240011, Barcelona
Investigational Site Number : 7240002, Barcelona
Lead Sponsor
Sanofi
INDUSTRY